Abstract
Regulation of gene expression by proteins associated with chromatin is a major, yet poorly understood, feature of differentiation and development. Recent genomic studies have highlighted the role of chromatin regulatory proteins in pathologies affecting cellular proliferation and cell cycle, such as cancer. Mass spectrometry-based proteomics approaches have, in the last decade, provided a wealth of information on the dynamic nature of the proteome during cellular differentiation. Label-based approaches have predominated the literature, however, with the development of increasingly sensitive mass spectrometers and liquid chromatographic systems; label-free techniques offer a compelling alternative. Using these approaches, a vast repertoire of proteins have been identified in the proteome of undifferentiated and differentiating stem cells, including transcription factors, chromatin-modifying complexes, histone-modifying enzymes and signalling proteins which act in concert to regulate gene expression. Given the recent correlation between mutations in epigenetic machinery and the development and progression of various cancers, application of these approaches to the study cancer cell proteomes could provide valuable insights into the role of epigenetic reregulation in tumourogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001;19(3):193–204.
Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trail. Lancet. 2011;378(9806):1847–57.
Ruff CA, Fehlings MG. Neural stem cells in regenerative medicine: bridging the gap. Panminerva Med. 2010;52(2):125–47.
Takawa M, Masuda K, Kunizaki M, Daigo Y, Takagi K, Iwai Y, et al. Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker. Cancer Sci. 2011;102(7):1298–305.
Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol. 2011;13(5):497–505.
Strauss R, Hamerlik P, Lieber A, Bartek J. Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer. Mol Ther. 2012;20(5):887–97.
Vincent A, Van Seuningen I. Epigenetics, stem cells and epithelial cell fate. Differentiation. 2009;78(2–3):99–107.
Young RA. Control of the embryonic stem cell state. Cell. 2011;144(6):940–54.
Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403(6765):41–5.
Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011;469(7330):343–9.
Piatti P, Zeilner A, Lusser A. ATP-dependent chromatin remodeling factors and their roles in affecting nucleosome fiber composition. Int J Mol Sci. 2011;12(10):6544–65.
Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150(1):12–27.
Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 2007;21(5):525–30.
Popovic R, Licht JD. Emerging epigenetic targets and therapies in cancer medicine. Cancer Discov. 2012;2(5):405–13.
Pal R, Ravindran G. Assessment of pluripotent and multilineage differentiation potential of NTERA-2 cells as a model for studying human embryonic stem cells. Cell Prolif. 2006;39(6):585–98.
Steen H, Mann M. The ABC’s (and XYZ’s) of peptide sequencing. Nat Rev Mol Cell Biol. 2004 Sep;5(9):699–711.
Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1(5):376–86.
Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3(12):1154–69.
Chelius D, Bondarenko PV. Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res. 2002;1(4):317–23.
Liu H, Sadygov RG, Yates 3rd JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem. 2004;76(14):4193–201.
Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26(12):1367–72.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2006;126(4):663–76.
Takahashi K, Tanabe K, Ohnuki MA, Narita M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–72.
van den Berg DLC, Snoek T, Mullin NP, Yates A, et al. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell. 2010;6:369–81.
Pardo M, Lang B, Yu LA, Proser H, et al. An expanded Oct4 interaction network; implication for stem cell biology, development and disease. Cell Stem Cell. 2010;6:382–95.
Chaerkady R, Kerr CL, Marimuthu A, Kelkar DS, et al. Temporal analysis of neural differentiation using quantitative proteomics. J Proteome Res. 2009;8(3):1315–26.
Sarkar P, Collier TS, Randalf SM, Muddiman DC, et al. The subcellular proteome of undifferentiated human embryonic stem cells. J Proteomics. 2012;12:1–10.
Jadaliha M, Lee HJ, Pakzad M, Fathi A, Jeong SK, et al. Quantitative proteomic analysis of human embryonic stem cell differentiation by 8-plex iTRAQ labelling. PLoS One. 2012;7(6):e38532.
Pewsey E, Bruce C, Tonge P, Evans C, et al. Nuclear proteome dynamics in differentiating embryonic carcinoma (NTERA-2) cells. J Proteome Res. 2010;9:3412–26.
Cagney G, Park S, Chung C, Tong B, O’Dushlaine C, Shields DC, et al. Human tissue profiling with multidimensional protein identification technology. J Proteome Res. 2005;4(5):1757–67. PubMed PMID: 16212430.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Watson, A., Cagney, G. (2014). Proteome Analysis of Chromatin Complexes in Differentiating Stem Cells. In: Emili, A., Greenblatt, J., Wodak, S. (eds) Systems Analysis of Chromatin-Related Protein Complexes in Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7931-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7931-4_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7930-7
Online ISBN: 978-1-4614-7931-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)